Skip to main content

FDA Clears Zymo Research Coronavirus Sample Collection Device

NEW YORK — Zymo Research said on Thursday that it has received 510(k) clearance from the US Food and Drug Administration for its DNA/RNA Shield Collection Tube, allowing its use for SARS-CoV-2 testing.

According to Zymo, the product consists of a tube filled with proprietary transport medium that stabilizes SARS-CoV-2 RNA for up to 28 days at ambient temperatures. The tube may be kitted with a swab or sputum collection kit, the company said.

Last year, Irvine, California-based Zymo received CE-IVD marking for the DNA/RNA Shield Collection Tube, as well as two other sample collection devices.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.